Skip to main content

This is a promotional website intended for UK healthcare professionals. If you are a member of the public, please click here.

Home
  • RLT Home
  • Neuroendocrine tumours
  • Prostate cancer

Popular Search

  • prrt
  • masterclass
  • part
  • 2022
  • 2023

Recent News

Pluvicto Clinical Trials
LUTATHERA® (lutetium [177Lu] oxodotreotide) Safety Information
Coming soon
Search

You do not have an account yet? Register here.

Register with your e-mail address
Free specialist information, congresses, training opportunities and much more awaits you.

Register with E-mail

User login

Log in with your username and password

  • Forgot Password?
×

Ask Speakers

×

Medical Information Request

Welcome to the Radioligand Therapy Hub.

Please confirm whether you are a UK healthcare professional or a member of public.

Yes, I am a UK healthcare professional
No, I am a member of the public
Privacy policy
Cookie Settings
Terms of use
Site directory
©2024 Novartis Pharmaceuticals UK Limited. All rights reserved.
This site is intended for a UK healthcare professional audience and NHS relevant decision makers only.

Novartis Pharmaceuticals UK Limited is a limited liability company registered in England and Wales under number 119006.
Registered office: The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ

UK | April 2024 | AAA-Lu177-UK-2429